Biolase Expects Full-Year 2024 Revenue Of $52M-$53M, Up 6%-8% Y/Y Compared To The Consensus Of $53.01M; The Company Expects To Improves Loss From Operations By 50%-60%
Portfolio Pulse from Benzinga Newsdesk
Biolase projects its full-year 2024 revenue to be between $52M-$53M, reflecting a 6%-8% increase year-over-year, slightly below the consensus estimate of $53.01M. The company also anticipates improving its loss from operations by 50%-60%.
January 29, 2024 | 11:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biolase expects a modest revenue growth for 2024 and significant improvement in operational losses, which may be viewed positively by investors despite a slight miss on consensus revenue estimates.
Biolase's projection of increased revenue and reduced operational losses is generally a positive sign for investors, indicating potential for improved financial health and efficiency. However, the revenue forecast being slightly below consensus might temper the market's reaction, leading to a cautiously optimistic outlook.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100